Among other keyword-selected putative target genes, B-cell lymphoma 2 (BCL2), catalase (CAT), and cAMP responsive element binding protein 1 (CREB1) are reportedly down-regulated in the liver in NAFLD [36, 103, 104]. The gene discussed is CREB1; the disease is metabolic dysfunction-associated steatotic liver disease.